CytomX Therapeutics, Inc.CTMXNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank50
Studio
Year-over-Year Change

Return on equity

Percentile
P50
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
2025-17.54%+99.7%
2024-6988.82%-582873.9%
20231.20%-99.0%
2022115.82%-99.5%
202125244.01%+2927.6%
2020833.80%+516.9%
2019-200.02%-209.4%
2018-64.64%-4.8%
2017-61.66%+17.8%
2016-75.05%-